Opus Genetics
Price & Volume
Stats
See more52W Range | $0.65-$2.18 |
Market Cap | $35.6M |
Shares Short | 126,990 |
Financials
See moreRevenue (12 Mos) | $8.3M |
Revenue Growth (YoY) | -67.6% |
Gross Profit (12 Mos) | -$15.3M |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 14 days ago
PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath
Yahoo Finance • 18 days ago
Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns
Yahoo Finance • 21 days ago
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
Yahoo Finance • 29 days ago
Opus Genetics Announces Financial Results for Full Year 2024
About
CEO | Mr. George Magrath M.B.A., M.D., M.S. |
Address | 8 Davis Drive, Durham, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
